Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Safety and Pharmacokinetic Study of MB-102 Versus Iohexol and the Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types

NCT02772276 is registered in ClinicalTrials.gov with MediBeacon as lead sponsor.

NCT NCT02772276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02772276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Safety and Pharmacokinetic Study of MB-102 Versus Iohexol and the Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types
Lead sponsor
MediBeacon
Phase
Phase 2
Overall status
Completed
Start date
May 11, 2016
Completion date
August 4, 2021
Enrollment
234 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury